Replies to post #80937 on Ocata Therapeutics Inc fka OCAT

[lasers]

rumper Rather then get into a full discussion regarding cloning, probably better IMO to stay with $OCAT's autologous IPSC from the patient's own tissues. In that way there is no controversy while the DNA is 100% the patient's and fully acceptable no rejection to be concerned with.

Yes VCEL is 100% autologous technology from bone marrow with the same bad management difficult beginnings as $OCAT but now starting to run under new CEO lawyer Nick Colangelo. Paul Wotton and Nick Colangelo share many features of the same management style IMO and therefore a good fit for Wotton on VCEL's BOD.

[lasers]

rumper. $OCAT Paul Wotton has much to learn from VCEL business model. For those interested in VCEL

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110652105

VCEL currently has approx 55% Institutional ownership

$OCAT thru Paul Wotton will IMO be targeting higher Institutional ownership.